Leslie W. Kreis - 10%+ Owner at In8 Bio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
10%+ Owner
Stock Symbol
INAB on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Leslie W. Kreis since 11/21/2023

Holdings reported by Leslie W. Kreis for In8 Bio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.73M $3.84M $1.03 Oct 4, 2024 By Bios Fund III QP, LP
Common Stock 1.88M $1.93M $1.03 Oct 4, 2024 By Bios Fund II QP, LP
Common Stock 997K $1.03M $1.03 Oct 4, 2024 By BIOS Incysus Co-Invest I, LP
Common Stock 602K $620K $1.03 Oct 4, 2024 By Bios Fund III, NT, LP
Common Stock 574K $592K $1.03 Oct 4, 2024 By Bios Fund II, LP
Common Stock 571K $588K $1.03 Oct 4, 2024 By Bios Fund III, LP
Common Stock 251K $259K $1.03 Oct 4, 2024 By Bios Fund II NT, LP
Pre-Funded Warrants 1.28M Oct 4, 2024 By Bios Clinical Opportunity Fund, LP Common Stock
Series C Warrant 709K Oct 4, 2024 By Bios Clinical Opportunity Fund, LP Common Stock
Series A Warrant 574K Oct 4, 2024 By Bios Clinical Opportunity Fund, LP Common Stock
Series B Warrant 574K Oct 4, 2024 By Bios Clinical Opportunity Fund, LP Common Stock 574K
Stock Option 85K Oct 4, 2024 Indirect Common Stock 85K
Stock Option 85K Dec 13, 2023 Indirect Common Stock 85K

Transactions reported by Leslie W. Kreis for In8 Bio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.